1 / 17

MEASLES Richard Moriarty, MD University of Massachusetts Medical School

MEASLES Richard Moriarty, MD University of Massachusetts Medical School. Measles. Cause: RNA myxovirus Hosts: man and monkeys Spread: respiratory droplets Incubation: 2 weeks Attack rate: 90% Attack leads to lifelong immunity 30-40 million cases annually 242,000 deaths in 2006.

weylin
Download Presentation

MEASLES Richard Moriarty, MD University of Massachusetts Medical School

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MEASLES Richard Moriarty, MD University of Massachusetts Medical School

  2. Measles • Cause: RNA myxovirus • Hosts: man and monkeys • Spread: respiratory droplets • Incubation: 2 weeks • Attack rate: 90% • Attack leads to lifelong immunity • 30-40 million cases annually • 242,000 deaths in 2006

  3. Measles Symptoms • Incubation: 14 days • Fever • Cough • Coryza • Conjunctivitis • Malaise – “miserable” • Koplik spots • Rash: cephalo-caudad spread

  4. Measles Mortality • West Africa – 12% • Displaced populations – up to 30% • Developed countries – 0.02% • Overcrowding promotes spread • Poor nutrition increases complication risk • Measles often followed by other diseases • Measles makes bad nutrition worse • Vitamin A deficiency increases CFR

  5. Measles: Differential Diagnosis • Scarlet fever • Staphylococcal toxin diseases • Rubella • Drug rash – SJS • Infectious mononucleosis • Dengue

  6. Measles Complications • Bacterial superinfection • Respiratory: pneumonia (bacterial or giant cell), croup, bronchiolitis • GI tract: diarrhea, malnutrition • Skin: desquamation • Eyes: conjunctivitis, corneal ulcer, blindness • Mouth: buccal ulceration, cancrum oris • Hemorrhage • Acute encephalitis 1:1000

  7. Measles Complications – cont. • Decreased cell-mediated immunity • Reduced CMI may reduce rash but increase risk of giant cell pneumonia • Activation of latent TB

  8. Measles Treatment • Supportive care • Fever therapy • Hydration • Vitamin A • 200,000 IU once > age 1 year • 100,000 IU once if age 6-12 months • If eye complications 200,000 IU daily X 2 D

  9. Measles Prevention • One serotype • Live attenuated vaccine • Monovalent, bivalent or trivalent • Usually given at 9, 12 or 15 mos after maternally acquired IgG has fallen • Contraindicated in pregnancy, malignancy • Side effects: fever rash 5-10%

  10. Measles Vaccine Coverage

More Related